| Document |
Document Title |
|
JPS6148498B2 |
|
|
JPS6148501B2 |
|
|
JPS6148499B2 |
|
|
JPS6148497B2 |
|
|
JPS6148500B2 |
|
|
JPS61233620A |
1α, 3β-dihydroxysteroid-5-ene, an intermediate of 1α-hydroxy vitamin D2 and D3, was prepd. Thus, 1α-hydroxy or 1α, 2α-epoxysteroid-4,6-diene-3-one having immediately removable 6-substitute radical was reduced with alk. metal/liq. N...
|
|
JPS61233619A |
1α, 3β-dihydroxysteroid-5-ene, an intermediate of 1α-hydroxy vitamin D2 and D3, was prepd. Thus, 1α-hydroxy or 1α, 2α-epoxysteroid-4,6-diene-3-one having immediately removable 6-substitute radical was reduced with alk. metal/liq. N...
|
|
JPS6146454B2 |
|
|
JPS6145617B2 |
|
|
JPS6144864B2 |
|
|
JPS6141352B2 |
|
|
JPS6141351B2 |
|
|
JPS61205253A |
PURPOSE: To obtain a compound useful as a drug, by subjecting an optical isomer mixture of prostaglandin methyl ester to asymmetric hydrolysis with an enzyme. CONSTITUTION: An optical isomer mixture of 2W4 prostaglandin methyl esters sho...
|
|
JPS61501990A |
PCT No. PCT/SU85/00029 Sec. 371 Date Dec. 27, 1985 Sec. 102(e) Date Dec. 27, 1985 PCT Filed Apr. 24, 1985 PCT Pub. No. WO85/04875 PCT Pub. Date Nov. 7, 1985.Novel derivatives of 15(R+S)-fluoro-11,15-dideoxyprostaglandin E1 of the general...
|
|
JPS61204165A |
NEW MATERIAL:The compound of formula I {[A] is group of formula II or formula III}. EXAMPLE: 9,11-Dideoxy-11-metylene-prostaglandin D2 (hereinafter prostaglandin is abbreviated as PG). USE: A medicine expected to exhibit physiological ac...
|
|
JPS6140662B2 |
PGF alpha compounds are disclosed having as the lower side chain in which one of R4 and R5 hydroxyl and the other is alkoxy R6 is hydrogen or alkyl, m is 0-3, E represents oxygen or sulphur and R is hydrogen, halogen, alkyl, alkoxy or tr...
|
|
JPS61501915A |
9-halogen-prostane having the formula (I) wherein Hal represents a chlorine or fluorine atom in position $g(a) or $g(b); R1? represents the rest CH2?OH or the formula (A) with R2? representing a hydrogen atom, an alkyl, cycloalkyl, aryl ...
|
|
JPS61197573A |
NEW MATERIAL:The 5,6-epoxy-5,6-trans-vitamin D3 of formula. USE: It has vitamin D-like activity. PREPARATION: The compound of formula can be produced e.g. by reacting 5,6-trans-vitamin D3 with m-chloroperbenzoic acid in an inert solvent....
|
|
JPS61194063A |
NEW MATERIAL:1α-Hydroxy-26,27-dimethyl-vitamin D3 of formula. USE: A remedy for calcium dysbolism and osteoporosis. It has strong vitamin D activity and low toxicity. PREPARATION: The compound of formula can be produced by converting 1...
|
|
JPS61194065A |
NEW MATERIAL:1α,25-Dihydroxy-26,27-diethylvitamin D3. USE: A remedy for Ca dysbolism and osteoporosis. It has powerful vitamin D activity with reduced toxicity. PREPARATION: 1α,3β-Diacetoxychol-5-ene-24-ol is used as a starting compou...
|
|
JPS61194064A |
NEW MATERIAL:25-Hydroxy-26,27-dimethylvitamin D3. USE: A remedy for Ca dysbolism and osteoporosis. It has powerful vitamin D3 activity with reduced toxicity. PREPARATION: The reaction of 3β-tetrahydropyranyloxy-26,27-dinorcholest-5- ene...
|
|
JPS6136752B2 |
|
|
JPS6136510B2 |
|
|
JPS6136511B2 |
1-[3-Methyl-3,5,5-trialkoxy-pent-1-yn-1-yl]-2,6-dimethyl-cyc
lohex-1-enes, which may or may not be methyl-substituted in the 2- and/or 6-position, are obtained by reacting the corresponding 1-[3-methyl-but-1-yn-3-en-1-yl]-2,6-dimethyl-cy...
|
|
JPS6136512B2 |
|
|
JPS6136513B2 |
|
|
JPS61501703A |
(57)【要約】 本公報は電子出願前の出願データであるため
要約のデータは記録されません。
|
|
JPS61180718A |
(57) [Abstract] Since this gazette is application data in front of an electronic application, the data of an abstract is not recorded.
|
|
JPS61178959A |
1α, 3β-dihydroxysteroid-5-ene, an intermediate of 1α-hydroxy vitamin D2 and D3, was prepd. Thus, 1α-hydroxy or 1α, 2α-epoxysteroid-4,6-diene-3-one having immediately removable 6-substitute radical was reduced with alk. metal/liq. N...
|
|
JPS61179000A |
1α, 3β-dihydroxysteroid-5-ene, an intermediate of 1α-hydroxy vitamin D2 and D3, was prepd. Thus, 1α-hydroxy or 1α, 2α-epoxysteroid-4,6-diene-3-one having immediately removable 6-substitute radical was reduced with alk. metal/liq. N...
|
|
JPS6131103B2 |
Novel 11-desoxy-prostaglandin F2 derivatives of the formula I wherein R is selected from the group consisting of hydrogen, alkyl of 1 to 4 carbon atoms, an alkali metal, an equivalent of an alkaline earth metal, magnesium or organic amin...
|
|
JPS61151167A |
NEW MATERIAL:A compound shown by the formula I (R is anthracycline compound residue; wavy line is double bond of E form or Z form or their mixture). EXAMPLE: An acid amide of dl-Δ7-Prostaglandin A1 and daunomycin. USE: Having carcinosta...
|
|
JPS61151166A |
NEW MATERIAL:A compound shown by the formula I (R is aromatic substituted 1W4C hydrocarbon, 10W20C alkenyl, or steroid residue; wavy line is double bond of E form or Z form or their mixture). EXAMPLE: dl-(7E)-Δ7-Prostaglandin A1 benzyl ...
|
|
JPS6129360B2 |
|
|
JPS6129349B2 |
|
|
JPS61143354A |
The syntheses of 25,26-dehydro-1 alpha ,24R-dihydroxycholecalciferol and 25,26-dehydro-1 alpha ,24S-dihydroxycholecalciferol and the epimeric mixture which are useful as differentiation inducing agent and anti-proliferation agents are de...
|
|
JPS61140560A |
NEW MATERIAL:A compound shown by the formula I (R1 and R2 are H, or OH). EXAMPLE: 3β-Hydroxy-17β-(4-methylpentyloxy)-9,10-secoandrosta-5-,7,
10(19)-triene. USE: A remedy for myelogenous leukemia. Having low influence on calcium metabol...
|
|
JPS61137857A |
The syntheses of 25,26-dehydro-1 alpha ,23S-dihydroxycholecalciferol, 25,26-dehydro-1 alpha ,23R-dihydroxycholecalciferol, and the epimeric mixture thereof which are useful as differentiation inducing agents and anti-proliferation agents...
|
|
JPS6126970B2 |
NEW MATERIAL:A compound of formulaI(R is H, 1-4C alkyl; the wave line shows that hydroxyl bonds to the carbon atoms in the alpha- or beta-configuration; the double bonds between C2 and C3, C13 and C14 are trans) its cyclodextrin clathrat...
|
|
JPS6125010B2 |
|
|
JPS6123788B2 |
New derivatives of 8-dehydro-vitamin A obtained by vinylating or ethynylating and subsequently partially hydrogenating, 1-[3-methyl-octa-1-yne,3,5,-dien-7-on-1-yl]-2,6-dimethyl-cyc
lohex-1-ene or its 5- and/or 6-methyl derivatives, conve...
|
|
JPS61112053A |
PURPOSE: In producing the titled compound useful as violet perfume for common cosmetic from β-ionone as a raw material, to improve yield in improved selectivity industrially advantageously, by using a rutheniunm carbon catalyst. CONSTIT...
|
|
JPS6121944B2 |
|
|
JPS61109764A |
PURPOSE: To obtain the titled concentrate useful as a food colorant, etc., with simple apparatus and operation in high yield, by the membrane-separation of a carotene-containing fatty acid lower alkyl ester using a carotene-separation me...
|
|
JPS61109748A |
NEW MATERIAL:The 4-substituted-5-alkenylidene-2-cyclopentenone compound of formula I (R1 is 1W10C alkyl; R2 is 1W10C substituted or unsubstituted alkyl; R3 is H or OH-protecting group). EXAMPLE: 4-(ω-Hydroxy-2-heptenyl)-5-(4-hydroxy-2-o...
|
|
JPS61106597A |
Syntheses of 24R,25- and 24S,25-dihydroxycholesterol 24,25-ketals and alkanoyl derivatives thereof, intermediates in the preparation of the biologically important metabolite and derivative, respectively, of vitamin D3, are described.
|
|
JPS61106598A |
Syntheses of 24R,25- and 24S,25-dihydroxycholesterol 24,25-ketals and alkanoyl derivatives thereof, intermediates in the preparation of the biologically important metabolite and derivative, respectively, of vitamin D3, are described.
|
|
JPS61106596A |
Syntheses of 24R,25- and 24S,25-dihydroxycholesterol 24,25-ketals and alkanoyl derivatives thereof, intermediates in the preparation of the biologically important metabolite and derivative, respectively, of vitamin D3, are described.
|
|
JPS61106567A |
Syntheses of 24R,25- and 24S,25-dihydroxycholesterol 24,25-ketals and alkanoyl derivatives thereof, intermediates in the preparation of the biologically important metabolite and derivative, respectively, of vitamin D3, are described.
|
|
JPS61100538A |
NEW MATERIAL:The cyclopentene alcohol compound of formula I [A is H and B is H or OH-protecting group (provided that R2is H), or A and B together form a bond (provided that R2 is H or OH-protecting group); R1 is substituted or unsubstitu...
|
